LifeMD Inc LFMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Novo Nordisk Launches Discounted Subscription Program for Wegovy Obesity Drugs — Update
-
Novo Nordisk Launches Discounted Subscription Program for Wegovy Obesity Drugs
-
LifeMD Shares Rise After Company Offers Novo Nordisk's Wegovy
-
GoodRX, Weight Watchers, LifeMD Offering Novo Nordisk's New Weight-Loss Pill
-
Novo Nordisk's Wegovy Pill Now Broadly Available Across U.S.
Trading Information
- Previous Close Price
- $4.73
- Day Range
- $4.59–4.83
- 52-Week Range
- $2.56–12.72
- Bid/Ask
- $4.56 / $4.96
- Shares Outstanding
- 48.36M
- Market Cap
- $224.40M
- Volume/Avg
- 510,043 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 22.93
- Price/Sales
- 1.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 384
- Website
- https://www.lifemd.com
Valuation
|
Metric
|
LFMD
|
|---|---|
Price/Earnings (Normalized) | 22.93 |
Price/Book Value | 15.43 |
Price/Sales | 1.25 |
Price/Cash Flow | — |
Price/Earnings
LFMD
Financial Strength
|
Metric
|
LFMD
|
|---|---|
Quick Ratio | 0.89 |
Current Ratio | 1.04 |
Interest Coverage | −28.29 |
Quick Ratio
LFMD
Profitability
|
Metric
|
LFMD
|
|---|---|
Return on Assets (Normalized) | −13.23% |
Return on Equity (Normalized) | −132.16% |
Return on Invested Capital (Normalized) | −40.28% |
Return on Assets
LFMD
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|&#>lC#M^ | LOCK|T! | $31B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|%X^d> | $14B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|<Wj? | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|mMcX | $14B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|M% | $10B | |||
| HealthEquity Inc
HQY
| — | LOCK|!<r? | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|%kj^f | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|z@% | $7B | |||
| 10x Genomics Inc Ordinary Shares - Class A
TXG
| — | LOCK|>r | $5B | |||
| Waystar Holding Corp
WAY
| — | LOCK|?#d | $4B |
United States